TY - CONF T1 - Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy. JO - CLINICAL CANCER RESEARCH UR - http://eprints.whiterose.ac.uk/131051/ PY - 2017/12/01 AU - Mueller LME AU - Parrish C AU - Migneco G AU - Scott GB AU - Holmes M AU - Melcher AA AU - Lawson MA AU - Cook G AU - Errington-Mais F ED - VL - 23 IS - 24 SP - 44 EP - 44 Y2 - 2025/04/12 ER -